Cora Schlesinger
Growth, contrarian, long only

GTx Inc.: Well, The Package Is Late To Arrive, But It's On Its Way

After a long silence, GTx speaks.

This article is based on information obtained from the recorded replay of the Bio CEO and Investor Conference held on Feb 10. Aside from it, GTx has been in a silent period since a brief earnings call held Nov 12, 2013. The company has presented clinical data at several well-respected academic meetings in 2012 and 2013, including the Oct 24 15th Annual Lung Cancer Conference; the Dec 12 San Antonio Breast Cancer Symposium; and the Jan 14 ASCO Genitourinary Cancer Conference. However, no direct company information has been released since the Nov 12 call. At that point there had been no announced contact with the regulators, the FDA and EMEA. This...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details